FDA Approves Genentech’s Tecentriq in Combination With a Fluoropyrimidine and Oxaliplatin for the Adjuvant Treatment of a Certain Type of Stage III Colon Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 59.62 +0.51 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.11 | 52 Week High | $35.13 | |||
| Open | $58.65 | 52 Week Low | $28.10 | |||
| Day High | $59.83 | P/E | N/A | |||
| Day Low | $58.41 | EPS | $0.00 | |||
| Volume | 946,295 | |||||
